Home

DANIEL B SOLAND

CIK 1318485 · CHIEF OPERATING OFFICER · last filed 2025-06-02

DANIEL B SOLAND is a CHIEF OPERATING OFFICER who has filed 53 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for ACAD, was dated Jun 2, 2025. Across all open-market trades the lifetime net is +$169.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.17M

Companies

5

Total Filings

53

Lifetime Open-Market Net

$169.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACAD Director 44,041 $26.01 $1.15M $234.9K 14 2025-06-02
DBVT Director 2,000 $13.50 $27.0K $24.3K 2 2023-08-03
Aceragen, Inc. (IDRA) Delisted CHIEF OPERATING OFFICER 4,638 $7.22 $33.5K $98.5K 7 2022-07-07
KalVista Pharmaceuticals, Inc. (KALV) Delisted Director 10,000 $27.00 $270.0K $118.7K 5 2021-10-01
VIROPHARMA INC (VPHM) Delisted VP, Chief Operating Officer 148,188 — — -$306.6K 24 2014-01-10

Recent Filings

53 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-06-02 ACAD Mixed +9,387 $0 EDGAR
2024-05-31 ACAD Mixed +6,652 $0 EDGAR
2023-08-03 DBVT Buy (P) +15,000 $24.3K EDGAR
2023-06-05 ACAD Mixed +18,002 $0 EDGAR
2022-07-07 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
2022-06-09 ACAD Grant (A) — $0 EDGAR
2022-04-04 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
2022-01-26 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
2021-10-01 KalVista Pharmaceuticals, Inc. (KALV) Delisted Grant (A) — $0 EDGAR
2021-07-12 Aceragen, Inc. (IDRA) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 53
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.